<VariationArchive VariationID="97381" VariationName="NM_000348.4(SRD5A2):c.656del (p.Phe219fs)" VariationType="Deletion" Accession="VCV000097381" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2014-02-20" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="103273" VariationID="97381">
      <GeneList>
        <Gene Symbol="SRD5A2" FullName="steroid 5 alpha-reductase 2" GeneID="6716" HGNC_ID="HGNC:11285" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="31522480" stop="31663009" display_start="31522480" display_stop="31663009" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="31749655" stop="31806039" display_start="31749655" display_stop="31806039" Strand="-" />
          </Location>
          <OMIM>607306</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000348.4(SRD5A2):c.656del (p.Phe219fs)</Name>
      <CanonicalSPDI>NC_000002.12:31529348:AAAAA:AAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="31529349" stop="31529349" display_start="31529349" display_stop="31529349" variantLength="1" positionVCF="31529348" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="31754419" stop="31754419" display_start="31754419" display_stop="31754419" variantLength="1" positionVCF="31754418" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F219fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.31754423del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.31754423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.31529353del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.31529353del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008365.1" sequenceAccession="NG_008365" sequenceVersion="1" change="g.56623del">
            <Expression>NG_008365.1:g.56623del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000348.4" sequenceAccession="NM_000348" sequenceVersion="4" change="c.656del" MANESelect="true">
            <Expression>NM_000348.4:c.656del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000339.2" sequenceAccession="NP_000339" sequenceVersion="2" change="p.Phe219fs">
            <Expression>NP_000339.2:p.Phe219fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA224872" DB="ClinGen" />
        <XRef Type="rs" ID="61748127" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000348.4(SRD5A2):c.656del (p.Phe219fs) AND not provided" Accession="RCV000083630" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-09-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000348.4(SRD5A2):c.656del (p.Phe219fs) AND 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" Accession="RCV003500502" Version="1">
        <ClassifiedConditionList TraitSetID="853">
          <ClassifiedCondition DB="MedGen" ID="C0268297">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-01" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2014-02-20" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20190539</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23329752</ID>
        </Citation>
        <DescriptionHistory Dated="2017-12-19">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5821" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency</ElementValue>
                <XRef ID="MONDO:0009923" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudovaginal perineoscrotal hypospadias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Male pseudohermaphroditism due to 5-alpha-reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial incomplete male pseudohermaphroditism, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ElementValue>
                <XRef ID="57514000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPSH</ElementValue>
                <XRef Type="MIM" ID="264600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508993" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5680" />
                <XRef ID="5680" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="753" DB="Orphanet" />
              <XRef ID="C0268297" DB="MedGen" />
              <XRef ID="MONDO:0009923" DB="MONDO" />
              <XRef Type="MIM" ID="264600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="203519" SubmissionDate="2012-05-02" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="reichardt_11" />
        <ClinVarAccession Accession="SCV000115716" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="University of Sydney Medical Foundation" OrgID="500310" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.31754423delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SRD5A2_2007_12_06</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203293" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:59908|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000616885" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.656delT variant in the SRD5A2 gene (also referred to as c.655delT) has been reported previously in association with autosomal recessive 5-alpha-reductase deficiency when present in the homozygous state or when in trans with another disease-causing variant (Ko et al., 2010; Fan et al., 2017; Wang et al., 2004). Functional studies on transfected COS-7 cells demonstrated that the pathogenic variant resulted in a dramatic reduction in 5-alpha-reductase activity (Zhang et al., 2011). This frameshift pathogenic variant replaces the typical last 36 amino acid residues in the SRD5A2 protein with 59 different amino acid residues. This change is expected to alter the normal structure and function of the resultant protein. The c.656delT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.656delT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRD5A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000348.3:c.656delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7978011" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4827472|MedGen:C0268297" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004292406" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20190539</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23329752</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the SRD5A2 gene (p.Phe219Serfs*60). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 36 amino acid(s) of the SRD5A2 protein and extend the protein by 23 additional amino acid residues. This variant is present in population databases (rs9332962, gnomAD 0.01%). This frameshift has been observed in individual(s) with steroid-5 alpha-reductase deficiency (PMID: 20190539, 23329752). This variant is also known as c.Tdel219. ClinVar contains an entry for this variant (Variation ID: 97381). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRD5A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.31754419del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268297" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7978011" TraitType="Disease" MappingType="XRef" MappingValue="C0268297" MappingRef="MedGen">
        <MedGen CUI="C0268297" Name="3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203293" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="203519" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

